{ "format" : "linked-data-api", "version" : "0.2", "result" : {"_about" : "https://eldaddp.azurewebsites.net/answeredquestions.text?legislature.prefLabel=House+of+Commons&min-answer.questionFirstAnswered.=2019-05-21T13%3A17%3A05.177Z&tablingMemberConstituency=Central+Ayrshire&min-ddpModified.=2023-09-15T14%3A51%3A26.762Z&hansardHeading=Human+Papillomavirus%3A+Vaccination", "definition" : "https://eldaddp.azurewebsites.net/meta/answeredquestions.text?legislature.prefLabel=House+of+Commons&min-answer.questionFirstAnswered.=2019-05-21T13%3A17%3A05.177Z&tablingMemberConstituency=Central+Ayrshire&min-ddpModified.=2023-09-15T14%3A51%3A26.762Z&hansardHeading=Human+Papillomavirus%3A+Vaccination", "extendedMetadataVersion" : "https://eldaddp.azurewebsites.net/answeredquestions.text?legislature.prefLabel=House+of+Commons&min-answer.questionFirstAnswered.=2019-05-21T13%3A17%3A05.177Z&tablingMemberConstituency=Central+Ayrshire&_metadata=all&min-ddpModified.=2023-09-15T14%3A51%3A26.762Z&hansardHeading=Human+Papillomavirus%3A+Vaccination", "first" : "https://eldaddp.azurewebsites.net/answeredquestions.text?_page=0&legislature.prefLabel=House+of+Commons&min-answer.questionFirstAnswered.=2019-05-21T13%3A17%3A05.177Z&tablingMemberConstituency=Central+Ayrshire&min-ddpModified.=2023-09-15T14%3A51%3A26.762Z&hansardHeading=Human+Papillomavirus%3A+Vaccination", "hasPart" : "https://eldaddp.azurewebsites.net/answeredquestions.text?legislature.prefLabel=House+of+Commons&min-answer.questionFirstAnswered.=2019-05-21T13%3A17%3A05.177Z&tablingMemberConstituency=Central+Ayrshire&min-ddpModified.=2023-09-15T14%3A51%3A26.762Z&hansardHeading=Human+Papillomavirus%3A+Vaccination", "isPartOf" : "https://eldaddp.azurewebsites.net/answeredquestions.text?legislature.prefLabel=House+of+Commons&min-answer.questionFirstAnswered.=2019-05-21T13%3A17%3A05.177Z&tablingMemberConstituency=Central+Ayrshire&min-ddpModified.=2023-09-15T14%3A51%3A26.762Z&hansardHeading=Human+Papillomavirus%3A+Vaccination", "items" : [{"_about" : "http://data.parliament.uk/resources/1701315", "AnsweringBody" : [{"_value" : "Foreign, Commonwealth and Development Office"}
      ], "answer" : {"_about" : "http://data.parliament.uk/resources/1701315/answer", "answerText" : {"_value" : "<p>The UK supports human papillomavirus (HPV) vaccination programmes in developing countries through Gavi, the Vaccine Alliance. The UK is the second largest donor to Gavi, having committing £1.65 billion over 2021-2025. The UK was a vocal advocate for inclusion of the HPV vaccine into Gavi's portfolio to help protect the most vulnerable girls from the leading cause of cervical cancer. Since 2014 Gavi has fully immunised <del class=\"ministerial\">48.2 <\/del><ins class=\"ministerial\">16.3<\/ins> million girls and aims to immunise a total of 86 million girls by the end of 2025.<\/p>"}
        , "answeringMember" : {"_about" : "http://data.parliament.uk/members/1211", "label" : {"_value" : "Biography information for Mr Andrew Mitchell"}
        }
        , "answeringMemberConstituency" : {"_value" : "Sutton Coldfield"}
        , "answeringMemberPrinted" : {"_value" : "Mr Andrew Mitchell"}
        , "dateOfAnswer" : {"_value" : "2024-04-23", "_datatype" : "dateTime"}
        , "isMinisterialCorrection" : {"_value" : "true", "_datatype" : "boolean"}
        , "previousAnswerVersion" : {"_about" : "http://data.parliament.uk/resources/1701315/answer/previousversion/29716", "answeringMember" : {"_about" : "http://data.parliament.uk/members/1211", "label" : {"_value" : "Biography information for Mr Andrew Mitchell"}
          }
          , "answeringMemberConstituency" : {"_value" : "Sutton Coldfield"}
          , "answeringMemberPrinted" : {"_value" : "Mr Andrew Mitchell"}
        }
        , "questionFirstAnswered" : [{"_value" : "2024-04-23T12:54:04.407Z", "_datatype" : "dateTime"}
        ], "questionFirstMinisteriallyCorrected" : [{"_value" : "2024-05-03T09:49:01.423Z", "_datatype" : "dateTime"}
        ]}
      , "answeringDeptId" : {"_value" : "208"}
      , "answeringDeptShortName" : {"_value" : "Foreign, Commonwealth and Development Office"}
      , "answeringDeptSortName" : {"_value" : "Foreign, Commonwealth and Development Office"}
      , "date" : {"_value" : "2024-04-16", "_datatype" : "dateTime"}
      , "hansardHeading" : {"_value" : "Human Papillomavirus: Vaccination"}
      , "houseId" : {"_value" : "1"}
      , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"}
      }
      ], "questionText" : "To ask the Deputy Foreign Secretary, what steps his Department is taking to support the roll-out of human papillomavirus vaccines worldwide.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"}
      , "tablingMember" : {"_about" : "http://data.parliament.uk/members/4385", "label" : {"_value" : "Biography information for Dr Philippa Whitford"}
      }
      , "tablingMemberConstituency" : {"_value" : "Central Ayrshire"}
      , "tablingMemberPrinted" : [{"_value" : "Dr Philippa Whitford"}
      ], "uin" : "22019"}
    ], "itemsPerPage" : 10, "page" : 0, "startIndex" : 1, "totalResults" : 1, "type" : ["http://purl.org/linked-data/api/vocab#ListEndpoint", "http://purl.org/linked-data/api/vocab#Page"]}
}